Clinical Trials in Detroit

Showing 2841-2860 of 16,931 trials

Sustained Immunity to COVID-19 as Measured by SARS-CoV-2 Serology Assays

NCT04562285

The primary objective is to assess the ability of COVID-19 IgG and IgM assays to detect an immune response in COVID-19 patients in the Henry Ford Health System (HFHS), both during hospitalization and over the following 12 months.

Covid19

Henry Ford Health System829 participantsStarted Jun 2020

Detroit, Michigan, United States

COMPLETEDPhase 3< 1 mile

Study of Effectiveness of Axicabtagene Ciloleucel Compared to Standard of Care Therapy in Patients With Relapsed/Refractory Diffuse Large B Cell Lymphoma

NCT03391466

The goal of this clinical study is to assess whether axicabtagene ciloleucel therapy improves the clinical outcome compared with standard of care second-line therapy in participants with relapsed/refractory diffuse large B-cell lymphoma (DLBCL).

Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL)

Kite, A Gilead Company359 participantsStarted Jan 2018

Gilbert, Arizona, United States • Phoenix, Arizona, United States • La Jolla, California, United States +69 more locations

Sustained Immunity to COVID-19 as Measured by SARS-CoV-2 Serology Assays

Study of Effectiveness of Axicabtagene Ciloleucel Compared to Standard of Care Therapy in Patients With Relapsed/Refractory Diffuse Large B Cell Lymphoma

Find Trials by Condition in Detroit

A Study to Evaluate Efficacy, Safety and Tolerability in Antiretroviral Therapy (ART)-Experienced Participants of at Least 50 Years of Age Living With Human Immunodeficiency Virus (HIV) With Virologic Suppression Who Switch to DTG/3TC FDC From BIC/FTC/TAF

Long-term Evaluation of Nasopharyngeal Airway in Hypotonia

Maturation of Arteriovenous Fistula With Automated Sonography Assessments Trial

RECOVER-VITAL: Platform Protocol to Measure the Effects of Antiviral Therapies on Long COVID Symptoms

Reversal of Atrial Substrate to Prevent Atrial Fibrillation Cohort Study

Study of Efficacy and Safety of Dabrafenib in Combination With Trametinib in Previously Treated Patients With Metastatic, Radio-active Iodine Refractory BRAF V600E Mutation Positive Differentiated Thyroid Cancer

A Research Study to See How Well the New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Level in People With Type 2 Diabetes Compared to Insulin Glargine Taken Daily With Insulin Aspart (COMBINE 3)

Acalabrutinib Safety Study in Untreated and Relapsed or Refractory Chronic Lymphocytic Leukemia Patients

A Study Using Flash Glucose Measurements for a New Once-weekly Insulin (Insulin Icodec) in People With Type 2 Diabetes Who Have Not Used Insulin Before (ONWARDS 9)

Study to Evaluate Immunogenicity and Safety of a High-Dose Influenza Vaccine in Adults 50 Through 64 Years of Age

Effect of Moderate Renal Impairment and Race/Ethnicity on Treosulfan Pharmacokinetics

AAV Gene Therapy Clinical Study in Adult Classic PKU (PHEdom)

A Clinical Study to Assess the Efficacy and Safety of Alpha DaRT224 for the Treatment of Patients With Recurrent Cutaneous Squamous Cell Carcinoma

FiberLocker® System Augmentation of Rotator Cuff Repairs

Phase I Trial of the Selective Inhibitor of Nuclear Export, KPT-330, in Relapsed Childhood ALL and AML

Stellate Ganglion Block for PTSD

Alpha Radiation Emitters Device for the Treatment of Pancreatic Cancer With Chemotherapy for the Treatment of Locally Advanced and Metastatic Pancreatic Cancer

A Phase 1, Randomized, Double-blind, Placebo-controlled Study Evaluating AMG 691 in Healthy Participants and Participants With Mild-to-Moderate Asthma